Cynthia L. Anderson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Cynthia L. Anderson
Earlier roles on record: CFO at Vistagen Therapeutics, Inc. (VTGN) until October 15, 2025. Vistagen Therapeutics, Inc. reported in an 8-K filed September 15, 2025 that Cynthia L. Anderson resigned as Chief Financial Officer and principal financial and accounting officer, effective October 15, 2025.
“On September 10, 2025, Vistagen Therapeutics, Inc. (the "Company") received notice from Cynthia L. Anderson, the Company's Chief Financial Officer and principal financial and accounting officer, of her decision to resign from the Company effective October 15, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-10-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.